These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20008032)

  • 1. The 'neuroadrenergic hypothesis' in hypertension: current evidence.
    Grassi G; Seravalle G; Quarti-Trevano F
    Exp Physiol; 2010 May; 95(5):581-6. PubMed ID: 20008032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late sympathetic activation in hypertension.
    Mancia G; Di Rienzo M; Giannattasio C; Parati G; Grassi G
    Scand Cardiovasc J Suppl; 1998; 47():9-14. PubMed ID: 9540128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential hypertension and the sympathetic nervous system.
    Grassi G; Quarti-Trevano F; Dell'oro R; Mancia G
    Neurol Sci; 2008 May; 29 Suppl 1():S33-6. PubMed ID: 18545892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the sympathetic nervous system in essential arterial hypertension and organ damage].
    Grassi G; Mancia G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():115S-120S. PubMed ID: 8562257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.
    Grassi G
    Hypertens Res; 2006 Nov; 29(11):839-47. PubMed ID: 17345783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.
    Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Arenare F; Spaziani D; Mancia G
    Hypertension; 2009 Feb; 53(2):205-9. PubMed ID: 19124679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic activity, blood pressure variability and end organ damage in hypertension.
    Mancia G; Di Rienzo M; Parati G; Grassi G
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S3-8. PubMed ID: 9321734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.
    Grassi G
    Hypertension; 2009 Oct; 54(4):690-7. PubMed ID: 19720958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autonomic nervous system in arterial hypertension].
    Grassi G
    Ital Heart J Suppl; 2001 Aug; 2(8):850-6. PubMed ID: 11582717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sympathetic nervous system in human hypertension.
    Mancia G; Grassi G; Parati G; Zanchetti A
    Acta Physiol Scand Suppl; 1997; 640():117-21. PubMed ID: 9401621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of variability in arterial blood pressure at rest using spectral analysis in hypertensive patients.
    Siché JP; Tremel F; Comparat V; de Gaudemaris R; Mallion JM
    J Hypertens; 1995 Jan; 13(1):147-53. PubMed ID: 7759845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic nervous system: role in hypertension and in chronic kidney disease.
    Grassi G; Bertoli S; Seravalle G
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):46-51. PubMed ID: 22080859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Rho-kinase in the brainstem enhances sympathetic drive in mice with heart failure.
    Ito K; Kimura Y; Hirooka Y; Sagara Y; Sunagawa K
    Auton Neurosci; 2008 Nov; 142(1-2):77-81. PubMed ID: 18762460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human sympathetic nervous system: its relevance in hypertension and heart failure.
    Parati G; Esler M
    Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased regional sympathetic nervous activity in human hypertension: causes and consequences.
    Esler M; Lambert G; Jennings G
    J Hypertens Suppl; 1990 Dec; 8(7):S53-7. PubMed ID: 1965656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic mechanisms in left ventricular hypertrophy: significance and clinical implications.
    Ram CV
    Indian Heart J; 1993; 45(1):21-4. PubMed ID: 8103506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroadrenergic disarray in pseudo-resistant and resistant hypertension.
    Grassi G; Bombelli M; Buzzi S; Volpe M; Brambilla G
    Hypertens Res; 2014 Jun; 37(6):479-83. PubMed ID: 24572914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation.
    Grassi G; Seravalle G; Brambilla G; Mancia G
    Can J Cardiol; 2012 May; 28(3):311-7. PubMed ID: 22244774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.